Literature DB >> 7718169

A phase I/II study of salvage radiosurgery in the treatment of recurrent brain metastases.

P Davey1, P F O'Brien, M L Schwartz, P W Cooper.   

Abstract

Radiosurgery has been advocated as a salvage treatment for relapsed patients with brain metastases. This report describes a phase I/II study of salvage radiosurgery for patients previously treated with whole brain irradiation. The study was opened in March 1989 and the last patient was treated in July 1992. All patients have been followed to recurrence at the radiosurgically treated site or to death. Twenty progressing metastases in 12 patients were treated using 14 radiosurgical procedures. The radiation dose was always 25 Gy with the 90% isodose volume encompassing all enhancing tumour. Nineteen metastases were evaluable at +4 weeks. There were no instances of progressive disease; there were three complete responses, six partial responses, and 10 metastases remained unchanged. Median survival from the date of radiosurgery was 6 months. Nine of 12 patients eventually failed at the radiosurgically treated site (two remain alive). Radiosurgery at the time of relapse provides temporary control of recurrent brain metastases with acceptable toxicity.

Entities:  

Mesh:

Year:  1994        PMID: 7718169     DOI: 10.3109/02688699409101186

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  8 in total

1.  A phase II trial of temozolomide for patients with recurrent or progressive brain metastases.

Authors:  L E Abrey; J D Olson; J J Raizer; M Mack; A Rodavitch; D Y Boutros; M G Malkin
Journal:  J Neurooncol       Date:  2001-07       Impact factor: 4.130

2.  Gamma knife stereotactic radiosurgery for the management of incidentally-identified brain metastasis from non-small cell lung cancer.

Authors:  Nicholas F Marko; John H Suh; Sam T Chao; Gene H Barnett; Michael A Vogelbaum; Steven Toms; Robert J Weil; Lilyana Angelov
Journal:  J Neurooncol       Date:  2011-03-23       Impact factor: 4.130

3.  Chemosensitized radiosurgery for recurrent brain metastases.

Authors:  David Roberge; Luis Souhami; Marie-Andrée Fortin; Jean-François Pouliot
Journal:  J Neurooncol       Date:  2012-08-22       Impact factor: 4.130

4.  The efficacy and limitations of stereotactic radiosurgery as a salvage treatment after failed whole brain radiotherapy for brain metastases.

Authors:  Shoji Yomo; Motohiro Hayashi
Journal:  J Neurooncol       Date:  2013-05-10       Impact factor: 4.130

5.  Tumor control and incidence of radiation necrosis after reirradiation with stereotactic radiosurgery for brain metastases.

Authors:  Breanne E Terakedis; Randy L Jensen; Kenneth Boucher; Dennis C Shrieve
Journal:  J Radiosurg SBRT       Date:  2014

6.  Current standards in the management of cerebral metastases.

Authors:  Pablo Goetz; Julius O Ebinu; David Roberge; Gelareh Zadeh
Journal:  Int J Surg Oncol       Date:  2011-11-10

Review 7.  The role of retreatment in the management of recurrent/progressive brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mario Ammirati; Charles S Cobbs; Mark E Linskey; Nina A Paleologos; Timothy C Ryken; Stuart H Burri; Anthony L Asher; Jay S Loeffler; Paula D Robinson; David W Andrews; Laurie E Gaspar; Douglas Kondziolka; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Roy A Patchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-03       Impact factor: 4.130

8.  Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.

Authors:  Raef Awad; Gerald Fogarty; Angela Hong; Patricia Kelly; Diana Ng; Daniel Santos; Lauren Haydu
Journal:  Radiat Oncol       Date:  2013-03-18       Impact factor: 3.481

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.